| | | | | |
RNAC Cartesian Therapeutics, Inc. Common Stock | €8,7324 | -1,93 % | €272,24M | €56,44K | |
FUND Sprott Focus Trust, Inc. | €9,2299 | -0,83 % | €272,08M | €21,27K | |
FATE Fate Therapeutics, Inc. | €2,1960 | +0,39 % | €271,95M | €901,14K | |
NMRA Neumora Therapeutics, Inc. Common Stock | €1,3467 | +4,67 % | €271,78M | €459,94K | |
GALT Galectin Therapeutics Inc. | €3,5599 | +4,01 % | €271,63M | €249,71K | |
NREF NexPoint Real Estate Finance, Inc. | €14,7456 | -0,92 % | €271,61M | €33,48K | |
POLE Andretti Acquisition Corp. II Class A Ordinary Shares | €9,2728 | -0,19 % | €271,36M | €395,44 | |
PSBD Palmer Square Capital BDC Inc. | €8,8353 | -0,39 % | €271,33M | €44,89K | |
| €2,7793 | -8,99 % | €271,14M | €1,01M | |
| €5,6529 | +0,92 % | €270,96M | €27,85K | |
SMTI Sanara MedTech Inc. Common Stock | €29,7399 | +0,00 % | €270,71M | €167,28K | |
MLP Maui Land & Pineapple Co. | €13,7162 | -0,44 % | €270,68M | €15,93K | |
AFB Alliance National Municipal Income Fund, Inc. | €9,3629 | -0,23 % | €270,49M | €36,63K | |
| €36,6452 | +3,06 % | €270,46M | €24,40K | |
TVA Texas Ventures Acquisition III Corp Class A Ordinary Share | €9,0498 | +0,09 % | €270,46M | €2,28K | |
